 | • レポートコード：MRC2Q12-03736 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、タクロリムスAPIの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にタクロリムスAPIのグローバル市場のxxx％を占める「0.98」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「カプセル剤」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 タクロリムスAPIの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのタクロリムスAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 タクロリムスAPIのグローバル主要プレイヤーには、Hangzhou Zhongmei Huadong Pharmaceutical、Guangzhou Tosun Pharmaceutical、Chunghwa Chemical Synthesis & Biotech、ChemWerth Inc、Dr. Reddy's Laboratories、Zeon Health Industries、Fishfa Biogenics、Teva API、Apotex Fermentation Inc.、Astellas Pharma、Bills Biotech、CKD Bio Corporation、Concord Biotech、JOYANG LABORATORIES、Lek Pharmaceuticals、Murli Krishna Pharma、Viruj Pharmaceuticals Pvt. Ltd、Zhejiang Hisun Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 タクロリムスAPI市場は、種類と用途によって区分されます。世界のタクロリムスAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 0.98、0.99、その他 【用途別セグメント】 カプセル剤、注射剤、軟膏剤、点眼剤、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - タクロリムスAPI製品概要 - 種類別市場（0.98、0.99、その他） - 用途別市場（カプセル剤、注射剤、軟膏剤、点眼剤、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のタクロリムスAPI販売量予測2017-2028 - 世界のタクロリムスAPI売上予測2017-2028 - タクロリムスAPIの地域別販売量 - タクロリムスAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別タクロリムスAPI販売量 - 主要メーカー別タクロリムスAPI売上 - 主要メーカー別タクロリムスAPI価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（0.98、0.99、その他） - タクロリムスAPIの種類別販売量 - タクロリムスAPIの種類別売上 - タクロリムスAPIの種類別価格 ・用途別市場規模（カプセル剤、注射剤、軟膏剤、点眼剤、その他） - タクロリムスAPIの用途別販売量 - タクロリムスAPIの用途別売上 - タクロリムスAPIの用途別価格 ・北米市場 - 北米のタクロリムスAPI市場規模（種類別、用途別） - 主要国別のタクロリムスAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのタクロリムスAPI市場規模（種類別、用途別） - 主要国別のタクロリムスAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のタクロリムスAPI市場規模（種類別、用途別） - 主要国別のタクロリムスAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のタクロリムスAPI市場規模（種類別、用途別） - 主要国別のタクロリムスAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのタクロリムスAPI市場規模（種類別、用途別） - 主要国別のタクロリムスAPI市場規模（トルコ、サウジアラビア） ・企業情報 Hangzhou Zhongmei Huadong Pharmaceutical、Guangzhou Tosun Pharmaceutical、Chunghwa Chemical Synthesis & Biotech、ChemWerth Inc、Dr. Reddy's Laboratories、Zeon Health Industries、Fishfa Biogenics、Teva API、Apotex Fermentation Inc.、Astellas Pharma、Bills Biotech、CKD Bio Corporation、Concord Biotech、JOYANG LABORATORIES、Lek Pharmaceuticals、Murli Krishna Pharma、Viruj Pharmaceuticals Pvt. Ltd、Zhejiang Hisun Pharmaceutical ・産業チェーン及び販売チャネル分析 - タクロリムスAPIの産業チェーン分析 - タクロリムスAPIの原材料 - タクロリムスAPIの生産プロセス - タクロリムスAPIの販売及びマーケティング - タクロリムスAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - タクロリムスAPIの産業動向 - タクロリムスAPIのマーケットドライバー - タクロリムスAPIの課題 - タクロリムスAPIの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Tacrolimus API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Tacrolimus API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Tacrolimus API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Tacrolimus API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Tacrolimus API include Hangzhou Zhongmei Huadong Pharmaceutical, Guangzhou Tosun Pharmaceutical, Chunghwa Chemical Synthesis & Biotech, ChemWerth Inc, Dr. Reddy’s Laboratories, Zeon Health Industries, Fishfa Biogenics, Teva API and Apotex Fermentation Inc., etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Tacrolimus API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Tacrolimus API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Tacrolimus API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Tacrolimus API market. Further, it explains the major drivers and regional dynamics of the global Tacrolimus API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Hangzhou Zhongmei Huadong Pharmaceutical
Guangzhou Tosun Pharmaceutical
Chunghwa Chemical Synthesis & Biotech
ChemWerth Inc
Dr. Reddy’s Laboratories
Zeon Health Industries
Fishfa Biogenics
Teva API
Apotex Fermentation Inc.
Astellas Pharma
Bills Biotech
CKD Bio Corporation
Concord Biotech
JOYANG LABORATORIES
Lek Pharmaceuticals
Murli Krishna Pharma
Viruj Pharmaceuticals Pvt. Ltd
Zhejiang Hisun Pharmaceutical
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Tacrolimus API Segment by Purity
0.98
0.99
Others
Tacrolimus API Segment by Application
Capsules
Injection
Ointments
Eye Drops
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Tacrolimus API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Tacrolimus API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Tacrolimus API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Tacrolimus API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Tacrolimus API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tacrolimus API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Tacrolimus API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Tacrolimus API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hangzhou Zhongmei Huadong Pharmaceutical, Guangzhou Tosun Pharmaceutical, Chunghwa Chemical Synthesis & Biotech, ChemWerth Inc, Dr. Reddy’s Laboratories, Zeon Health Industries, Fishfa Biogenics, Teva API and Apotex Fermentation Inc., etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Tacrolimus API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Tacrolimus API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Tacrolimus API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tacrolimus API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Tacrolimus API Product Introduction
1.2 Market by Purity
1.2.1 Global Tacrolimus API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Market by Application
1.3.1 Global Tacrolimus API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Capsules
1.3.3 Injection
1.3.4 Ointments
1.3.5 Eye Drops
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Tacrolimus API Production
2.1 Global Tacrolimus API Production Capacity (2017-2028)
2.2 Global Tacrolimus API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Tacrolimus API Production by Region
2.3.1 Global Tacrolimus API Historic Production by Region (2017-2022)
2.3.2 Global Tacrolimus API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Tacrolimus API Sales in Volume & Value Estimates and Forecasts
3.1 Global Tacrolimus API Sales Estimates and Forecasts 2017-2028
3.2 Global Tacrolimus API Revenue Estimates and Forecasts 2017-2028
3.3 Global Tacrolimus API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Tacrolimus API Sales by Region
3.4.1 Global Tacrolimus API Sales by Region (2017-2022)
3.4.2 Global Sales Tacrolimus API by Region (2023-2028)
3.5 Global Tacrolimus API Revenue by Region
3.5.1 Global Tacrolimus API Revenue by Region (2017-2022)
3.5.2 Global Tacrolimus API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Tacrolimus API Production Capacity by Manufacturers
4.2 Global Tacrolimus API Sales by Manufacturers
4.2.1 Global Tacrolimus API Sales by Manufacturers (2017-2022)
4.2.2 Global Tacrolimus API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Tacrolimus API in 2021
4.3 Global Tacrolimus API Revenue by Manufacturers
4.3.1 Global Tacrolimus API Revenue by Manufacturers (2017-2022)
4.3.2 Global Tacrolimus API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Tacrolimus API Revenue in 2021
4.4 Global Tacrolimus API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Tacrolimus API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Tacrolimus API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Tacrolimus API Sales by Purity
5.1.1 Global Tacrolimus API Historical Sales by Purity (2017-2022)
5.1.2 Global Tacrolimus API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Tacrolimus API Sales Market Share by Purity (2017-2028)
5.2 Global Tacrolimus API Revenue by Purity
5.2.1 Global Tacrolimus API Historical Revenue by Purity (2017-2022)
5.2.2 Global Tacrolimus API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Tacrolimus API Revenue Market Share by Purity (2017-2028)
5.3 Global Tacrolimus API Price by Purity
5.3.1 Global Tacrolimus API Price by Purity (2017-2022)
5.3.2 Global Tacrolimus API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Tacrolimus API Sales by Application
6.1.1 Global Tacrolimus API Historical Sales by Application (2017-2022)
6.1.2 Global Tacrolimus API Forecasted Sales by Application (2023-2028)
6.1.3 Global Tacrolimus API Sales Market Share by Application (2017-2028)
6.2 Global Tacrolimus API Revenue by Application
6.2.1 Global Tacrolimus API Historical Revenue by Application (2017-2022)
6.2.2 Global Tacrolimus API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Tacrolimus API Revenue Market Share by Application (2017-2028)
6.3 Global Tacrolimus API Price by Application
6.3.1 Global Tacrolimus API Price by Application (2017-2022)
6.3.2 Global Tacrolimus API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Tacrolimus API Market Size by Purity
7.1.1 North America Tacrolimus API Sales by Purity (2017-2028)
7.1.2 North America Tacrolimus API Revenue by Purity (2017-2028)
7.2 North America Tacrolimus API Market Size by Application
7.2.1 North America Tacrolimus API Sales by Application (2017-2028)
7.2.2 North America Tacrolimus API Revenue by Application (2017-2028)
7.3 North America Tacrolimus API Sales by Country
7.3.1 North America Tacrolimus API Sales by Country (2017-2028)
7.3.2 North America Tacrolimus API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Tacrolimus API Market Size by Purity
8.1.1 Europe Tacrolimus API Sales by Purity (2017-2028)
8.1.2 Europe Tacrolimus API Revenue by Purity (2017-2028)
8.2 Europe Tacrolimus API Market Size by Application
8.2.1 Europe Tacrolimus API Sales by Application (2017-2028)
8.2.2 Europe Tacrolimus API Revenue by Application (2017-2028)
8.3 Europe Tacrolimus API Sales by Country
8.3.1 Europe Tacrolimus API Sales by Country (2017-2028)
8.3.2 Europe Tacrolimus API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Tacrolimus API Market Size by Purity
9.1.1 Asia Pacific Tacrolimus API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Tacrolimus API Revenue by Purity (2017-2028)
9.2 Asia Pacific Tacrolimus API Market Size by Application
9.2.1 Asia Pacific Tacrolimus API Sales by Application (2017-2028)
9.2.2 Asia Pacific Tacrolimus API Revenue by Application (2017-2028)
9.3 Asia Pacific Tacrolimus API Sales by Region
9.3.1 Asia Pacific Tacrolimus API Sales by Region (2017-2028)
9.3.2 Asia Pacific Tacrolimus API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Tacrolimus API Market Size by Purity
10.1.1 Latin America Tacrolimus API Sales by Purity (2017-2028)
10.1.2 Latin America Tacrolimus API Revenue by Purity (2017-2028)
10.2 Latin America Tacrolimus API Market Size by Application
10.2.1 Latin America Tacrolimus API Sales by Application (2017-2028)
10.2.2 Latin America Tacrolimus API Revenue by Application (2017-2028)
10.3 Latin America Tacrolimus API Sales by Country
10.3.1 Latin America Tacrolimus API Sales by Country (2017-2028)
10.3.2 Latin America Tacrolimus API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Tacrolimus API Market Size by Purity
11.1.1 Middle East and Africa Tacrolimus API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Tacrolimus API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Tacrolimus API Market Size by Application
11.2.1 Middle East and Africa Tacrolimus API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Tacrolimus API Revenue by Application (2017-2028)
11.3 Middle East and Africa Tacrolimus API Sales by Country
11.3.1 Middle East and Africa Tacrolimus API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Tacrolimus API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Hangzhou Zhongmei Huadong Pharmaceutical
12.1.1 Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
12.1.2 Hangzhou Zhongmei Huadong Pharmaceutical Overview
12.1.3 Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
12.2 Guangzhou Tosun Pharmaceutical
12.2.1 Guangzhou Tosun Pharmaceutical Corporation Information
12.2.2 Guangzhou Tosun Pharmaceutical Overview
12.2.3 Guangzhou Tosun Pharmaceutical Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Guangzhou Tosun Pharmaceutical Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Guangzhou Tosun Pharmaceutical Recent Developments
12.3 Chunghwa Chemical Synthesis & Biotech
12.3.1 Chunghwa Chemical Synthesis & Biotech Corporation Information
12.3.2 Chunghwa Chemical Synthesis & Biotech Overview
12.3.3 Chunghwa Chemical Synthesis & Biotech Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Chunghwa Chemical Synthesis & Biotech Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Chunghwa Chemical Synthesis & Biotech Recent Developments
12.4 ChemWerth Inc
12.4.1 ChemWerth Inc Corporation Information
12.4.2 ChemWerth Inc Overview
12.4.3 ChemWerth Inc Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 ChemWerth Inc Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 ChemWerth Inc Recent Developments
12.5 Dr. Reddy’s Laboratories
12.5.1 Dr. Reddy’s Laboratories Corporation Information
12.5.2 Dr. Reddy’s Laboratories Overview
12.5.3 Dr. Reddy’s Laboratories Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Dr. Reddy’s Laboratories Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Dr. Reddy’s Laboratories Recent Developments
12.6 Zeon Health Industries
12.6.1 Zeon Health Industries Corporation Information
12.6.2 Zeon Health Industries Overview
12.6.3 Zeon Health Industries Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Zeon Health Industries Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Zeon Health Industries Recent Developments
12.7 Fishfa Biogenics
12.7.1 Fishfa Biogenics Corporation Information
12.7.2 Fishfa Biogenics Overview
12.7.3 Fishfa Biogenics Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Fishfa Biogenics Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Fishfa Biogenics Recent Developments
12.8 Teva API
12.8.1 Teva API Corporation Information
12.8.2 Teva API Overview
12.8.3 Teva API Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Teva API Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Teva API Recent Developments
12.9 Apotex Fermentation Inc.
12.9.1 Apotex Fermentation Inc. Corporation Information
12.9.2 Apotex Fermentation Inc. Overview
12.9.3 Apotex Fermentation Inc. Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Apotex Fermentation Inc. Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Apotex Fermentation Inc. Recent Developments
12.10 Astellas Pharma
12.10.1 Astellas Pharma Corporation Information
12.10.2 Astellas Pharma Overview
12.10.3 Astellas Pharma Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Astellas Pharma Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Astellas Pharma Recent Developments
12.11 Bills Biotech
12.11.1 Bills Biotech Corporation Information
12.11.2 Bills Biotech Overview
12.11.3 Bills Biotech Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Bills Biotech Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Bills Biotech Recent Developments
12.12 CKD Bio Corporation
12.12.1 CKD Bio Corporation Corporation Information
12.12.2 CKD Bio Corporation Overview
12.12.3 CKD Bio Corporation Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 CKD Bio Corporation Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 CKD Bio Corporation Recent Developments
12.13 Concord Biotech
12.13.1 Concord Biotech Corporation Information
12.13.2 Concord Biotech Overview
12.13.3 Concord Biotech Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Concord Biotech Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Concord Biotech Recent Developments
12.14 JOYANG LABORATORIES
12.14.1 JOYANG LABORATORIES Corporation Information
12.14.2 JOYANG LABORATORIES Overview
12.14.3 JOYANG LABORATORIES Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 JOYANG LABORATORIES Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 JOYANG LABORATORIES Recent Developments
12.15 Lek Pharmaceuticals
12.15.1 Lek Pharmaceuticals Corporation Information
12.15.2 Lek Pharmaceuticals Overview
12.15.3 Lek Pharmaceuticals Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Lek Pharmaceuticals Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Lek Pharmaceuticals Recent Developments
12.16 Murli Krishna Pharma
12.16.1 Murli Krishna Pharma Corporation Information
12.16.2 Murli Krishna Pharma Overview
12.16.3 Murli Krishna Pharma Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Murli Krishna Pharma Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Murli Krishna Pharma Recent Developments
12.17 Viruj Pharmaceuticals Pvt. Ltd
12.17.1 Viruj Pharmaceuticals Pvt. Ltd Corporation Information
12.17.2 Viruj Pharmaceuticals Pvt. Ltd Overview
12.17.3 Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Viruj Pharmaceuticals Pvt. Ltd Recent Developments
12.18 Zhejiang Hisun Pharmaceutical
12.18.1 Zhejiang Hisun Pharmaceutical Corporation Information
12.18.2 Zhejiang Hisun Pharmaceutical Overview
12.18.3 Zhejiang Hisun Pharmaceutical Tacrolimus API Sales, Price, Revenue and Gross Margin (2017-2022)
12.18.4 Zhejiang Hisun Pharmaceutical Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Zhejiang Hisun Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Tacrolimus API Industry Chain Analysis
13.2 Tacrolimus API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Tacrolimus API Production Mode & Process
13.4 Tacrolimus API Sales and Marketing
13.4.1 Tacrolimus API Sales Channels
13.4.2 Tacrolimus API Distributors
13.5 Tacrolimus API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Tacrolimus API Industry Trends
14.2 Tacrolimus API Market Drivers
14.3 Tacrolimus API Market Challenges
14.4 Tacrolimus API Market Restraints
15 Key Finding in The Global Tacrolimus API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Tacrolimus API Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 0.98
Table 3. Major Manufacturers of 0.99
Table 4. Major Manufacturers of Others
Table 5. Global Tacrolimus API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 6. Global Tacrolimus API Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 7. Global Tacrolimus API Production by Region (2017-2022) & (Tons)
Table 8. Global Tacrolimus API Production Market Share by Region (2017-2022)
Table 9. Global Tacrolimus API Production by Region (2023-2028) & (Tons)
Table 10. Global Tacrolimus API Production Market Share by Region (2023-2028)
Table 11. Global Tacrolimus API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Tacrolimus API Sales by Region (2017-2022) & (Tons)
Table 13. Global Tacrolimus API Sales Market Share by Region (2017-2022)
Table 14. Global Tacrolimus API Sales by Region (2023-2028) & (Tons)
Table 15. Global Tacrolimus API Sales Market Share by Region (2023-2028)
Table 16. Global Tacrolimus API Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Tacrolimus API Revenue Market Share by Region (2017-2022)
Table 18. Global Tacrolimus API Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Tacrolimus API Revenue Market Share by Region (2023-2028)
Table 20. Global Tacrolimus API Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 21. Global Tacrolimus API Capacity Market Share by Manufacturers (2017-2022)
Table 22. Global Tacrolimus API Sales by Manufacturers (2017-2022) & (Tons)
Table 23. Global Tacrolimus API Sales Market Share by Manufacturers (2017-2022)
Table 24. Global Tacrolimus API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Tacrolimus API Revenue Share by Manufacturers (2017-2022)
Table 26. Tacrolimus API Price by Manufacturers 2017-2022 (US$/Kg)
Table 27. Global Tacrolimus API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Tacrolimus API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tacrolimus API as of 2021)
Table 29. Tacrolimus API Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Tacrolimus API Product Offered
Table 31. Date of Manufacturers Enter into Tacrolimus API Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Tacrolimus API Sales by Purity (2017-2022) & (Tons)
Table 34. Global Tacrolimus API Sales by Purity (2023-2028) & (Tons)
Table 35. Global Tacrolimus API Sales Share by Purity (2017-2022)
Table 36. Global Tacrolimus API Sales Share by Purity (2023-2028)
Table 37. Global Tacrolimus API Revenue by Purity (2017-2022) & (US$ Million)
Table 38. Global Tacrolimus API Revenue by Purity (2023-2028) & (US$ Million)
Table 39. Global Tacrolimus API Revenue Share by Purity (2017-2022)
Table 40. Global Tacrolimus API Revenue Share by Purity (2023-2028)
Table 41. Tacrolimus API Price by Purity (2017-2022) & (US$/Kg)
Table 42. Global Tacrolimus API Price Forecast by Purity (2023-2028) & (US$/Kg)
Table 43. Global Tacrolimus API Sales by Application (2017-2022) & (Tons)
Table 44. Global Tacrolimus API Sales by Application (2023-2028) & (Tons)
Table 45. Global Tacrolimus API Sales Share by Application (2017-2022)
Table 46. Global Tacrolimus API Sales Share by Application (2023-2028)
Table 47. Global Tacrolimus API Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Tacrolimus API Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Tacrolimus API Revenue Share by Application (2017-2022)
Table 50. Global Tacrolimus API Revenue Share by Application (2023-2028)
Table 51. Tacrolimus API Price by Application (2017-2022) & (US$/Kg)
Table 52. Global Tacrolimus API Price Forecast by Application (2023-2028) & (US$/Kg)
Table 53. North America Tacrolimus API Sales by Purity (2017-2022) & (Tons)
Table 54. North America Tacrolimus API Sales by Purity (2023-2028) & (Tons)
Table 55. North America Tacrolimus API Revenue by Purity (2017-2022) & (US$ Million)
Table 56. North America Tacrolimus API Revenue by Purity (2023-2028) & (US$ Million)
Table 57. North America Tacrolimus API Sales by Application (2017-2022) & (Tons)
Table 58. North America Tacrolimus API Sales by Application (2023-2028) & (Tons)
Table 59. North America Tacrolimus API Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Tacrolimus API Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Tacrolimus API Sales by Country (2017-2022) & (Tons)
Table 62. North America Tacrolimus API Sales by Country (2023-2028) & (Tons)
Table 63. North America Tacrolimus API Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Tacrolimus API Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Tacrolimus API Sales by Purity (2017-2022) & (Tons)
Table 66. Europe Tacrolimus API Sales by Purity (2023-2028) & (Tons)
Table 67. Europe Tacrolimus API Revenue by Purity (2017-2022) & (US$ Million)
Table 68. Europe Tacrolimus API Revenue by Purity (2023-2028) & (US$ Million)
Table 69. Europe Tacrolimus API Sales by Application (2017-2022) & (Tons)
Table 70. Europe Tacrolimus API Sales by Application (2023-2028) & (Tons)
Table 71. Europe Tacrolimus API Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Tacrolimus API Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Tacrolimus API Sales by Country (2017-2022) & (Tons)
Table 74. Europe Tacrolimus API Sales by Country (2023-2028) & (Tons)
Table 75. Europe Tacrolimus API Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Tacrolimus API Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Tacrolimus API Sales by Purity (2017-2022) & (Tons)
Table 78. Asia Pacific Tacrolimus API Sales by Purity (2023-2028) & (Tons)
Table 79. Asia Pacific Tacrolimus API Revenue by Purity (2017-2022) & (US$ Million)
Table 80. Asia Pacific Tacrolimus API Revenue by Purity (2023-2028) & (US$ Million)
Table 81. Asia Pacific Tacrolimus API Sales by Application (2017-2022) & (Tons)
Table 82. Asia Pacific Tacrolimus API Sales by Application (2023-2028) & (Tons)
Table 83. Asia Pacific Tacrolimus API Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Tacrolimus API Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Tacrolimus API Sales by Region (2017-2022) & (Tons)
Table 86. Asia Pacific Tacrolimus API Sales by Region (2023-2028) & (Tons)
Table 87. Asia Pacific Tacrolimus API Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Tacrolimus API Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Tacrolimus API Sales by Purity (2017-2022) & (Tons)
Table 90. Latin America Tacrolimus API Sales by Purity (2023-2028) & (Tons)
Table 91. Latin America Tacrolimus API Revenue by Purity (2017-2022) & (US$ Million)
Table 92. Latin America Tacrolimus API Revenue by Purity (2023-2028) & (US$ Million)
Table 93. Latin America Tacrolimus API Sales by Application (2017-2022) & (Tons)
Table 94. Latin America Tacrolimus API Sales by Application (2023-2028) & (Tons)
Table 95. Latin America Tacrolimus API Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Tacrolimus API Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Tacrolimus API Sales by Country (2017-2022) & (Tons)
Table 98. Latin America Tacrolimus API Sales by Country (2023-2028) & (Tons)
Table 99. Latin America Tacrolimus API Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Tacrolimus API Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Tacrolimus API Sales by Purity (2017-2022) & (Tons)
Table 102. Middle East and Africa Tacrolimus API Sales by Purity (2023-2028) & (Tons)
Table 103. Middle East and Africa Tacrolimus API Revenue by Purity (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Tacrolimus API Revenue by Purity (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Tacrolimus API Sales by Application (2017-2022) & (Tons)
Table 106. Middle East and Africa Tacrolimus API Sales by Application (2023-2028) & (Tons)
Table 107. Middle East and Africa Tacrolimus API Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Tacrolimus API Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Tacrolimus API Sales by Country (2017-2022) & (Tons)
Table 110. Middle East and Africa Tacrolimus API Sales by Country (2023-2028) & (Tons)
Table 111. Middle East and Africa Tacrolimus API Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Tacrolimus API Revenue by Country (2023-2028) & (US$ Million)
Table 113. Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
Table 114. Hangzhou Zhongmei Huadong Pharmaceutical Description and Major Businesses
Table 115. Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 116. Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Hangzhou Zhongmei Huadong Pharmaceutical Recent Development
Table 118. Guangzhou Tosun Pharmaceutical Corporation Information
Table 119. Guangzhou Tosun Pharmaceutical Description and Major Businesses
Table 120. Guangzhou Tosun Pharmaceutical Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 121. Guangzhou Tosun Pharmaceutical Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Guangzhou Tosun Pharmaceutical Recent Development
Table 123. Chunghwa Chemical Synthesis & Biotech Corporation Information
Table 124. Chunghwa Chemical Synthesis & Biotech Description and Major Businesses
Table 125. Chunghwa Chemical Synthesis & Biotech Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 126. Chunghwa Chemical Synthesis & Biotech Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Chunghwa Chemical Synthesis & Biotech Recent Development
Table 128. ChemWerth Inc Corporation Information
Table 129. ChemWerth Inc Description and Major Businesses
Table 130. ChemWerth Inc Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 131. ChemWerth Inc Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. ChemWerth Inc Recent Development
Table 133. Dr. Reddy's Laboratories Corporation Information
Table 134. Dr. Reddy's Laboratories Description and Major Businesses
Table 135. Dr. Reddy's Laboratories Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 136. Dr. Reddy's Laboratories Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Dr. Reddy's Laboratories Recent Development
Table 138. Zeon Health Industries Corporation Information
Table 139. Zeon Health Industries Description and Major Businesses
Table 140. Zeon Health Industries Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 141. Zeon Health Industries Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Zeon Health Industries Recent Development
Table 143. Fishfa Biogenics Corporation Information
Table 144. Fishfa Biogenics Description and Major Businesses
Table 145. Fishfa Biogenics Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 146. Fishfa Biogenics Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Fishfa Biogenics Recent Development
Table 148. Teva API Corporation Information
Table 149. Teva API Description and Major Businesses
Table 150. Teva API Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 151. Teva API Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Teva API Recent Development
Table 153. Apotex Fermentation Inc. Corporation Information
Table 154. Apotex Fermentation Inc. Description and Major Businesses
Table 155. Apotex Fermentation Inc. Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 156. Apotex Fermentation Inc. Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Apotex Fermentation Inc. Recent Development
Table 158. Astellas Pharma Corporation Information
Table 159. Astellas Pharma Description and Major Businesses
Table 160. Astellas Pharma Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 161. Astellas Pharma Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Astellas Pharma Recent Development
Table 163. Bills Biotech Corporation Information
Table 164. Bills Biotech Description and Major Businesses
Table 165. Bills Biotech Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 166. Bills Biotech Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Bills Biotech Recent Development
Table 168. CKD Bio Corporation Corporation Information
Table 169. CKD Bio Corporation Description and Major Businesses
Table 170. CKD Bio Corporation Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 171. CKD Bio Corporation Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. CKD Bio Corporation Recent Development
Table 173. Concord Biotech Corporation Information
Table 174. Concord Biotech Description and Major Businesses
Table 175. Concord Biotech Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 176. Concord Biotech Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Concord Biotech Recent Development
Table 178. JOYANG LABORATORIES Corporation Information
Table 179. JOYANG LABORATORIES Description and Major Businesses
Table 180. JOYANG LABORATORIES Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 181. JOYANG LABORATORIES Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. JOYANG LABORATORIES Recent Development
Table 183. Lek Pharmaceuticals Corporation Information
Table 184. Lek Pharmaceuticals Description and Major Businesses
Table 185. Lek Pharmaceuticals Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 186. Lek Pharmaceuticals Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Lek Pharmaceuticals Recent Development
Table 188. Murli Krishna Pharma Corporation Information
Table 189. Murli Krishna Pharma Description and Major Businesses
Table 190. Murli Krishna Pharma Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 191. Murli Krishna Pharma Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Murli Krishna Pharma Recent Development
Table 193. Viruj Pharmaceuticals Pvt. Ltd Corporation Information
Table 194. Viruj Pharmaceuticals Pvt. Ltd Description and Major Businesses
Table 195. Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 196. Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. Viruj Pharmaceuticals Pvt. Ltd Recent Development
Table 198. Zhejiang Hisun Pharmaceutical Corporation Information
Table 199. Zhejiang Hisun Pharmaceutical Description and Major Businesses
Table 200. Zhejiang Hisun Pharmaceutical Tacrolimus API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 201. Zhejiang Hisun Pharmaceutical Tacrolimus API Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. Zhejiang Hisun Pharmaceutical Recent Development
Table 203. Key Raw Materials Lists
Table 204. Raw Materials Key Suppliers Lists
Table 205. Tacrolimus API Distributors List
Table 206. Tacrolimus API Customers List
Table 207. Tacrolimus API Market Trends
Table 208. Tacrolimus API Market Drivers
Table 209. Tacrolimus API Market Challenges
Table 210. Tacrolimus API Market Restraints
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
List of Figures
Figure 1. Tacrolimus API Product Picture
Figure 2. Global Tacrolimus API Market Share by Purity in 2021 & 2028
Figure 3. 0.98 Product Picture
Figure 4. 0.99 Product Picture
Figure 5. Others Product Picture
Figure 6. Global Tacrolimus API Market Share by Application in 2021 & 2028
Figure 7. Capsules
Figure 8. Injection
Figure 9. Ointments
Figure 10. Eye Drops
Figure 11. Others
Figure 12. Tacrolimus API Report Years Considered
Figure 13. Global Tacrolimus API Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 14. Global Tacrolimus API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Tacrolimus API Production Market Share by Region (2017-2022)
Figure 16. Global Tacrolimus API Production Market Share by Region (2023-2028)
Figure 17. Tacrolimus API Production Growth Rate in North America (2017-2028) & (Tons)
Figure 18. Tacrolimus API Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 19. Tacrolimus API Production Growth Rate in China (2017-2028) & (Tons)
Figure 20. Tacrolimus API Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 21. Global Tacrolimus API Sales 2017-2028 (Tons)
Figure 22. Global Tacrolimus API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 23. Global Tacrolimus API Revenue 2017-2028 (US$ Million)
Figure 24. Global Tacrolimus API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 25. Global Tacrolimus API Sales Market Share by Region (2017-2022)
Figure 26. Global Tacrolimus API Sales Market Share by Region (2023-2028)
Figure 27. North America Tacrolimus API Sales YoY (2017-2028) & (Tons)
Figure 28. North America Tacrolimus API Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Europe Tacrolimus API Sales YoY (2017-2028) & (Tons)
Figure 30. Europe Tacrolimus API Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Tacrolimus API Sales YoY (2017-2028) & (Tons)
Figure 32. Asia-Pacific Tacrolimus API Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Latin America Tacrolimus API Sales YoY (2017-2028) & (Tons)
Figure 34. Latin America Tacrolimus API Revenue YoY (2017-2028) & (US$ Million)
Figure 35. Middle East & Africa Tacrolimus API Sales YoY (2017-2028) & (Tons)
Figure 36. Middle East & Africa Tacrolimus API Revenue YoY (2017-2028) & (US$ Million)
Figure 37. The Tacrolimus API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 38. The Top 5 and 10 Largest Manufacturers of Tacrolimus API in the World: Market Share by Tacrolimus API Revenue in 2021
Figure 39. Tacrolimus API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 40. Global Tacrolimus API Sales Market Share by Purity (2017-2028)
Figure 41. Global Tacrolimus API Revenue Market Share by Purity (2017-2028)
Figure 42. Global Tacrolimus API Sales Market Share by Application (2017-2028)
Figure 43. Global Tacrolimus API Revenue Market Share by Application (2017-2028)
Figure 44. North America Tacrolimus API Sales Market Share by Purity (2017-2028)
Figure 45. North America Tacrolimus API Revenue Market Share by Purity (2017-2028)
Figure 46. North America Tacrolimus API Sales Market Share by Application (2017-2028)
Figure 47. North America Tacrolimus API Revenue Market Share by Application (2017-2028)
Figure 48. North America Tacrolimus API Sales Share by Country (2017-2028)
Figure 49. North America Tacrolimus API Revenue Share by Country (2017-2028)
Figure 50. United States Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 51. Canada Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 52. Europe Tacrolimus API Sales Market Share by Purity (2017-2028)
Figure 53. Europe Tacrolimus API Revenue Market Share by Purity (2017-2028)
Figure 54. Europe Tacrolimus API Sales Market Share by Application (2017-2028)
Figure 55. Europe Tacrolimus API Revenue Market Share by Application (2017-2028)
Figure 56. Europe Tacrolimus API Sales Share by Country (2017-2028)
Figure 57. Europe Tacrolimus API Revenue Share by Country (2017-2028)
Figure 58. Germany Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 59. France Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 60. U.K. Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 61. Italy Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 62. Russia Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 63. Asia Pacific Tacrolimus API Sales Market Share by Purity (2017-2028)
Figure 64. Asia Pacific Tacrolimus API Revenue Market Share by Purity (2017-2028)
Figure 65. Asia Pacific Tacrolimus API Sales Market Share by Application (2017-2028)
Figure 66. Asia Pacific Tacrolimus API Revenue Market Share by Application (2017-2028)
Figure 67. Asia Pacific Tacrolimus API Sales Share by Region (2017-2028)
Figure 68. Asia Pacific Tacrolimus API Revenue Share by Region (2017-2028)
Figure 69. China Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 70. Japan Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 71. South Korea Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 72. India Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 73. Australia Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 74. China Taiwan Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 75. Indonesia Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 76. Thailand Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 77. Malaysia Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 78. Latin America Tacrolimus API Sales Market Share by Purity (2017-2028)
Figure 79. Latin America Tacrolimus API Revenue Market Share by Purity (2017-2028)
Figure 80. Latin America Tacrolimus API Sales Market Share by Application (2017-2028)
Figure 81. Latin America Tacrolimus API Revenue Market Share by Application (2017-2028)
Figure 82. Latin America Tacrolimus API Sales Share by Country (2017-2028)
Figure 83. Latin America Tacrolimus API Revenue Share by Country (2017-2028)
Figure 84. Mexico Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 85. Brazil Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 86. Argentina Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 87. Middle East and Africa Tacrolimus API Sales Market Share by Purity (2017-2028)
Figure 88. Middle East and Africa Tacrolimus API Revenue Market Share by Purity (2017-2028)
Figure 89. Middle East and Africa Tacrolimus API Sales Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Tacrolimus API Revenue Market Share by Application (2017-2028)
Figure 91. Middle East and Africa Tacrolimus API Sales Share by Country (2017-2028)
Figure 92. Middle East and Africa Tacrolimus API Revenue Share by Country (2017-2028)
Figure 93. Turkey Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 94. Saudi Arabia Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 95. UAE Tacrolimus API Revenue (2017-2028) & (US$ Million)
Figure 96. Tacrolimus API Value Chain
Figure 97. Tacrolimus API Production Process
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed